SVCP
EW icon

Silicon Valley Capital Partners’s Edwards Lifesciences EW Stock Holding History

Silicon Valley Capital Partners’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$316K Buy
+3,952
New +$326K 0.03% 79
2023
Q2 		– Sell
-240
Closed -$19.9K – 352
2023
Q1 		$19.9K Buy
+240
New +$18.9K ﹤0.01% 138

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Silicon Valley Capital Partners's EW Position: Q1 2026 in Review

Silicon Valley Capital Partners opened a new position in Edwards Lifesciences (EW) in Q1 2026: 3,952 shares worth $316K. The stake represents 0.03% of the portfolio and ranks #79 among its holdings. This is a return to the name: Silicon Valley Capital Partners previously reported a position in EW as recently as Q1 2023.

Silicon Valley Capital Partners first reported a position in EW in Q1 2023 and has held it in 2 quarters since. 1,284 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Silicon Valley Capital Partners held 3,952 shares of Edwards Lifesciences worth $316K as of Q1 2026.
  • Edwards Lifesciences was a new Silicon Valley Capital Partners position in Q1 2026.
  • Edwards Lifesciences made up 0.03% of Silicon Valley Capital Partners's portfolio in Q1 2026, its #79 holding.
  • Silicon Valley Capital Partners first reported a position in Edwards Lifesciences in Q1 2023 and has held it in 2 quarters since.
  • 1,284 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Silicon Valley Capital Partners's 13F filing for Q1 2026, filed 19 May 2026.